Dr. Grivas on the Next Steps for Immunotherapy in Bladder Cancer

Petros Grivas, MD, PhD
Published: Wednesday, Dec 06, 2017



Petros Grivas, MD, PhD, medical oncologist, Cleveland Clinic, discusses next steps for immunotherapy for the treatment of patients with bladder cancer.

According to Grivas, this is a great environment because there are many ongoing clinical trials. There are close to 1000 clinical trials across tumor types evaluating different combinations of immunotherapy


Petros Grivas, MD, PhD, medical oncologist, Cleveland Clinic, discusses next steps for immunotherapy for the treatment of patients with bladder cancer.

According to Grivas, this is a great environment because there are many ongoing clinical trials. There are close to 1000 clinical trials across tumor types evaluating different combinations of immunotherapy

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Moving Forward From the Status Quo for the Treatment of Soft Tissue Sarcoma: Key Questions & New Answers to Optimize OutcomesAug 16, 20181.5
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Publication Bottom Border
Border Publication
x